WEBVTT - Novo and Dayforce Jumps; Apple Headset

0:00:00.080 --> 0:00:09.960
<v Speaker 1>Bloomberg Audio Studios, podcasts, radio news, The Stock Movers Report,

0:00:10.280 --> 0:00:13.440
<v Speaker 1>your roundup of companies making moves in the stock market,

0:00:13.680 --> 0:00:18.560
<v Speaker 1>harnessing the power of Bloomberg Data. Stockmovers is John Tucker's

0:00:18.560 --> 0:00:22.240
<v Speaker 1>a podcast. John decided to start out where I am John?

0:00:22.320 --> 0:00:25.439
<v Speaker 2>Did my body Mass Index this weekend? Yeah?

0:00:25.560 --> 0:00:28.000
<v Speaker 1>Came over did my BMI?

0:00:28.080 --> 0:00:32.959
<v Speaker 2>As they say, he said with Govy Novo nordis good

0:00:33.080 --> 0:00:36.440
<v Speaker 2>luck with that. Yeah, I mean I know a lot

0:00:36.479 --> 0:00:39.159
<v Speaker 2>of people who take it, but the side effects it

0:00:39.320 --> 0:00:42.839
<v Speaker 2>just you know, can vary from individual to individual. Now

0:00:42.880 --> 0:00:46.880
<v Speaker 2>there's apparently a new use for it. Novo shares advancing

0:00:46.920 --> 0:00:51.600
<v Speaker 2>after the drugmaker's blockbuster weight loss drug WEGV has now

0:00:51.640 --> 0:00:56.240
<v Speaker 2>received US approval to treat a serious form of liver disease.

0:00:57.200 --> 0:00:59.480
<v Speaker 2>The important part of this also is that they beat

0:00:59.480 --> 0:01:02.480
<v Speaker 2>one of their competitors, Eli Lilly to the US market,

0:01:03.040 --> 0:01:06.720
<v Speaker 2>So this particular approval gives Novo a big win in

0:01:06.760 --> 0:01:10.240
<v Speaker 2>the booming market for the GLP one drugs they of course,

0:01:10.280 --> 0:01:14.680
<v Speaker 2>have been popularized for weight loss. The drug makers started

0:01:14.720 --> 0:01:17.959
<v Speaker 2>the year as Europe's most valuable traded company, but it's

0:01:18.080 --> 0:01:22.320
<v Speaker 2>since lost about half of its value as it wrestles

0:01:22.360 --> 0:01:26.120
<v Speaker 2>with fierce competition in the obesity market. So the liver

0:01:26.200 --> 0:01:29.280
<v Speaker 2>clearance marks the second boost for Nova this month, after

0:01:29.360 --> 0:01:34.280
<v Speaker 2>disappointing data from Lily's obesity bill boosted investor hopes about

0:01:34.760 --> 0:01:39.119
<v Speaker 2>Novo's ability to Competegovie was clear for a disease known

0:01:39.160 --> 0:01:43.759
<v Speaker 2>as mash in adults with moderate to advance scar tissue

0:01:43.760 --> 0:01:46.880
<v Speaker 2>in the liver. A mash develops when fat builds up

0:01:46.920 --> 0:01:50.440
<v Speaker 2>in the liver, causing inflammation and potentially leading to more

0:01:50.480 --> 0:01:53.960
<v Speaker 2>serious conditions like cirrhosis and cancer. So Wgovie helps reverse

0:01:54.000 --> 0:01:58.160
<v Speaker 2>the damage to the liver, according to Novo nord Disk. Next,

0:01:59.200 --> 0:02:02.960
<v Speaker 2>let's go to a company called day Force, the ticker

0:02:03.040 --> 0:02:08.480
<v Speaker 2>symbol day so human resources management software provider. It is

0:02:08.520 --> 0:02:12.800
<v Speaker 2>the target of Tomo Bravo, the buyout firm planning to

0:02:12.840 --> 0:02:16.360
<v Speaker 2>take the Minneapolis based company private. This is a deal

0:02:16.560 --> 0:02:19.320
<v Speaker 2>that could be announced as soon as the coming weeks.

0:02:19.560 --> 0:02:23.320
<v Speaker 2>Day four shares they have fallen about the sixty percent

0:02:23.400 --> 0:02:26.680
<v Speaker 2>from their twenty twenty one peak, while the company increased

0:02:26.720 --> 0:02:30.040
<v Speaker 2>revenue more than seventy percent between twenty twenty one and

0:02:30.080 --> 0:02:33.639
<v Speaker 2>twenty twenty four and became more profitable again. This is

0:02:33.680 --> 0:02:39.520
<v Speaker 2>the enterprise software market. They make human resources software. This

0:02:39.720 --> 0:02:44.040
<v Speaker 2>market has had difficulties maintaining momentum after a run up

0:02:44.120 --> 0:02:49.560
<v Speaker 2>during the COVID nineteen lockdowns, and let's wrap up with

0:02:49.639 --> 0:02:53.679
<v Speaker 2>this one. We constantly asked the question Apple, where's its

0:02:53.760 --> 0:02:58.120
<v Speaker 2>mojo going? An interesting take from Mark German. He focuses

0:02:58.160 --> 0:03:02.520
<v Speaker 2>on Apple's Vision Pro headset. It isn't selling well for

0:03:02.560 --> 0:03:04.520
<v Speaker 2>a couple of reasons. First of all, it's thirty five

0:03:04.600 --> 0:03:07.360
<v Speaker 2>hundred dollars price sag, and then there's the lack of

0:03:07.400 --> 0:03:11.840
<v Speaker 2>sufficiently compelling features. There are other issues like a limited

0:03:11.919 --> 0:03:16.600
<v Speaker 2>array of custom applications and the device's weight and cumbersome

0:03:16.800 --> 0:03:21.080
<v Speaker 2>setup process. By all accounts, the device remains an extremely

0:03:21.280 --> 0:03:24.960
<v Speaker 2>niche product. Moreover, the headset doesn't feel like a priority

0:03:25.000 --> 0:03:27.960
<v Speaker 2>for Apple. On the the last earnings call, for instance,

0:03:28.280 --> 0:03:31.320
<v Speaker 2>Tim Cook almost seems surprised when a Wallstreet analyst quiz

0:03:31.400 --> 0:03:35.560
<v Speaker 2>him about the device and also the company's strategy. So

0:03:36.040 --> 0:03:38.120
<v Speaker 2>there you go. Mark Dermott strikes again on it.

0:03:39.400 --> 0:03:43.440
<v Speaker 1>The Stock Movers Report from Bloomberg Radio. Check back with

0:03:43.520 --> 0:03:46.080
<v Speaker 1>us throughout the day for the latest roundup of companies

0:03:46.160 --> 0:03:49.240
<v Speaker 1>making news on Wall Street and for the latest market

0:03:49.280 --> 0:03:53.720
<v Speaker 1>moving headlines. Listen to Bloomberg Radio Live. Catch us on YouTube,

0:03:53.840 --> 0:03:57.360
<v Speaker 1>Bloomberg dot com, and on Applecarplay and Android Auto with

0:03:57.400 --> 0:04:03.400
<v Speaker 1>the Bloomberg Business appe